ARCHIVE: This episode older than one year and is archived and available for $3 on the Premium page to help cover server costs. Thank you for understanding.
What is the future of psychedelic research and what has been discovered so far? I interview Rick Doblin, Ph.D., the founder of MAPS - the Multidisciplinary Association for Psychedelic Studies.
Rick Doblin, Ph.D., is the founder and president of MAPS (Multidisciplinary Association for Psychedelic Studies), which he founded in 1986. His dissertation (in Public Policy, at Harvard's Kennedy School of Government) was on "The Regulation of the Medical Use of Psychedelics and Marijuana," and his master's thesis (Harvard) focused on the attitudes and experiences of oncologists concerning the medical use of marijuana. His undergraduate thesis (New College of Florida) was a twenty-five year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He has also conducted a thirty-four year follow-up study to Tim Leary's Concord Prison experiment. Doblin has also studied with Stan Grof, M.D., and was in the first group to become certified as holotropic breathwork practitioners. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise "healthy" people, and to also become a legally licensed psychedelic therapist. He currently resides in Boston with his wife and three young children.
See www.maps.org for more information.